Engineered carbohydrate-active enzymes for glycan polymers synthesis
View Patent ↗The present invention relates to engineered carbohydrate-active enzyme constructs that are useful for glycan polymers synthesis. The construct comprises a CD domain from a GH, wherein the domain is conjugated to CBM3a via a peptidic linker. The invention also relates to a method of improving glycan polymer synthesis by using engineered carbohydrate active enzymes comprising a CD domain and CBM3a.
1. A construct comprising a Glycoside Hydrolase (GH) catalytic domain (CD),
wherein the GH CD is conjugated to a carbohydrate binding module (CBM) selected from carbohydrate binding module 1 (CBM1), carbohydrate binding module 3a (CBM3a), and carbohydrate binding module 17 (CBM17),
wherein the GH CD comprises amino acid residues 38-377 of SEQ ID NO. 6, with the proviso that in the GH CD at least one of the Glu amino acid residues at positions 180 and 303 of SEQ ID NO. 6 is mutated to an independently selected non-nucleophilic amino acid.
2. The construct of claim 1 , wherein the GH CD polypeptide comprising amino acid residues 38-377 of SEQ ID NO. 6 is capable of hydrolyzing at least one substrate selected from the group consisting of cellulose, mannan, galactomannan, and xylan.
3. The construct of claim 1 , wherein at least one applies:
(a) the carbohydrate binding module 1 (CBM1) comprises amino acid residues 420-459 of SEQ ID NO. 2;
(b) the carbohydrate binding module 3a (CBM3a) comprises amino acid residues 420-578 of SEQ ID NO. 6;
(c) the carbohydrate binding module 17 (CBM17) comprises amino acid residues 420-601 of SEQ ID NO. 4.
4. The construct of claim 1 , wherein the Glu amino acid residue at position 303 of SEQ ID NO. 6 is mutated to Gly or Ala.
5. The construct of claim 1 , wherein the Glu amino acid residue at position 180 of SEQ ID NO. 6 is mutated to Gly or Ala.
6. The construct of claim 1 , wherein the GH CD is conjugated to the CBM through a linker.
7. The construct of claim 6 , wherein the linker is peptidic.
8. The construct of claim 7 , wherein the linker comprises about 7-200 amino acids.
9. The construct of claim 7 , wherein the linker comprises about 15-41 amino acids.
10. The construct of claim 1 , wherein the N-terminus of the GH CD is conjugated to the C-terminus of the CBM through the linker.
11. The construct of claim 1 , wherein the C-terminus of the GH CD is conjugated to the N-terminus of the CBM through the linker.
12. The construct of claim 1 , which has higher glycan polymer synthesis activity than the mutated GH CD when not conjugated to the CBM.
13. The construct of claim 12 , which catalytic activity is at least 2-fold higher than the mutated GH CD when not conjugated to the CBM.
14. The construct of claim 1 , which is encoded by the nucleotide sequence of any of SEQ ID NOs. 15, 17, 19, 21, 23, 25, and 27.
15. The construct of claim 1 , which comprises the amino acid sequence of any of SEQ ID NOs. 16, 18, 20, 22, 24, 26, and 28.
16. A method for producing a glycan polymer, the method comprising contacting a glycosyl donor substrate with an effective amount of the construct of claim 1 .
17. The method of claim 16 , wherein the substrate includes at least one selected from the group consisting of cellobiose, glucose, xylose, and mannose.